Publications by authors named "Victoria Capel"

Despite research efforts full potential of siRNA-based therapeutics has not yet been fully realized due to a need for suitable, effective delivery formulations. Here, we examine a potential of a new class of water-soluble chitosans as siRNA platform for pulmonary delivery. The system is based on piperazine-substituted chitosans, a material designed to integrate established, safe application of chitosan for mucosal administration with novel properties: the piperazine-substituted chitosans are freely water-soluble at physiological pH, possess low cytotoxicity (no significant reduction in cell viability up to 0.

View Article and Find Full Text PDF

Despite research efforts, cell uptake processes determining siRNA silencing efficiency remain unclear. Here, we examine the relationship between in vitro cell culture models, cellular trafficking and siRNA silencing efficiency to provide a mechanistic insight on siRNA delivery system design. Model siRNA-polyplexes, based on chitosan as a 'classical' condensing agent, were applied to a panel of lung epithelial cell lines, H1299, A549 and Calu-3 and cell internalization levels, trafficking pathways and gene silencing assessed on exposure to pharmacological inhibitors.

View Article and Find Full Text PDF

Some new phosphorus(III) derivatives Ar(2)PX (X = Br, Cl, F or H), ArPX(2) (X = Br or Cl), Ar(3)P and Ar(t)BuPCl, with the 2,5-bis(trifluoromethyl)phenyl (Ar) substituent on phosphorus, have been prepared, and characterised by (31)P and (19)F NMR solution-state spectroscopy. The complexing ability of Ar(2)PX, Ar(3)P and Ar(t)BuPCl towards the dimeric platinum(II) complexes [PtY(μ-Y)(PEt(3))](2) (Y = Cl or Br, the latter for X = Br only) has also been investigated. Single-crystal X-ray diffraction studies at low temperature have been carried out for Ar(3)P, Ar(2)PCl and the hydrolysis or oxidation products Ar(2)P(H)OH and Ar(2)P(O)OH.

View Article and Find Full Text PDF